Ameliorating Role of Hydrogen-Rich Water Against NSAID-Induced Enteropathy via Reduction of ROS and Production of Short-Chain Fatty Acids.
水素水摂取によるNSAID誘発性腸症の改善:ROS低減と短鎖脂肪酸産生を介したメカニズムの検討
Abstract
This mouse study examined how hydrogen-rich water (HRW) affects indomethacin-induced small intestinal injury. Oral HRW administration for 5 days significantly reduced histological damage and suppressed inflammatory cytokine expression. Luminal reactive oxygen species (ROS) were markedly decreased in HRW-treated animals. Although gut microbiota composition was not altered by HRW, fecal microbiota transplantation (FMT) from HRW-fed mice into recipient animals attenuated intestinal injury. Cecal short-chain fatty acid (SCFA) concentrations were significantly elevated in HRW-treated mice compared with controls. In vitro co-culture experiments showed that cecal supernatants from HRW-treated animals increased interleukin-10 expression in RAW264 macrophage cells. These findings indicate that HRW protects intestinal mucosa through two complementary mechanisms: direct ROS scavenging and SCFA-mediated anti-inflammatory signaling.
Mechanism
HRW exerts dual protective effects: direct scavenging of luminal ROS including hydroxyl radicals, and elevation of cecal short-chain fatty acids that promote IL-10 production in macrophages, thereby suppressing intestinal inflammation.
Bibliographic
- Authors
- Akita Y, Higashiyama M, Kurihara C, Ito S, Nishii S, Mizoguchi A, et al.
- Journal
- Dig Dis Sci
- Year
- 2023
- PMID
- 36478314
- DOI
- 10.1007/s10620-022-07781-5
- PMC
- PMC9734488
Tags
Delivery context
Hydrogen-rich water is a low-risk delivery route, but the achievable systemic hydrogen dose is bounded. For clinical applications, inhalation is the most efficient route; inhalation, however, carries explosion risk, and concentration matters (empirical LFL of 10% applies to inhalation environments; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).
Safety notes
See also: